| CAT No: | CL-LPB-05 |
| CAS No: | 320337-48-2 |
| Mol.F: | C26H19CLFN3O3 |
| Mol.Wt.: | 475.9 |
| Chemical Name: | (5-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)furan-2-yl)methanol |
| Inventory Status: | Custom synthesis |
This impurity is related to Lapatinib Impurity 4 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
Lapatinib Impurity 4 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:(5-(4-((3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)furan-2-yl)methanolCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Lapatinib Molecular Formula: C26H19CLFN3O3
Molecular Weight: 475.9
Storage: Store in a cool, dry place.
| Product Name: | Lapatinib Impurity 4 |
| CAS No: | 320337-48-2 |
| Mol.F.: | C26H19CLFN3O3 |
| Mol.Wt.: | 475.9 |
Cat. No: CL-LPB-NO-01
CAS No: NA
Mol. F: C29H25ClFN5O5S
Mol. Wt: 610.06
Inv. Status: Custom Synthesis
Cat. No: CL-LPB-NO-02
CAS No: NA
Mol. F: C29H24ClFN6O6S
Mol. Wt: 639.05
Inv. Status: Custom Synthesis
Cat. No: CL-LPB-NO-03
CAS No: NA
Mol. F: C29H25ClFN5O5S
Mol. Wt: 610.06
Inv. Status: Custom Synthesis
Cat. No: CL-LPB-01
CAS No: 231277-92-2
Mol. F: C29H26CIFN4O4S
Mol. Wt: 581.1
Inv. Status: Custom Synthesis
Cat. No: CL-LPB-02
CAS No: 1268997-70-1
Mol. F: C22H21ClN4O4S
Mol. Wt: 472.9
Inv. Status: Custom Synthesis
Cat. No: CL-LPB-03
CAS No: NA
Mol. F: C29H25ClFN4O4S
Mol. Wt: 580.1
Inv. Status: Custom Synthesis
Cat. No: CL-LPB-04
CAS No: NA
Mol. F: C26H20ClFN4O2 : HCl
Mol. Wt: 474.9 : 36.5
Inv. Status: Custom Synthesis
Cat. No: CL-LPB-13
CAS No: 903597-10-4
Mol. F: C10H10IN3
Mol. Wt: 299.1
Inv. Status: Custom Synthesis
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: